Atul Chopra
Directeur Technique/Scientifique/R&D chez Aceragen, Inc. (North Carolina)
Fortune : 968 947 $ au 31/07/2023
Profil
Atul Chopra is associated with Aceragen, Inc. (North Carolina) as a Scientific Advisor.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACERAGEN, INC.
14,31% | 19/07/2023 | 1 205 158 ( 14,31% ) | 968 947 $ | 31/07/2023 |
Postes actifs de Atul Chopra
| Sociétés | Poste | Début |
|---|---|---|
Aceragen, Inc. (North Carolina)
 Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aceragen, Inc. (North Carolina)
Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Health Technology |
